Bing Jiang

2.8k total citations · 2 hit papers
72 papers, 2.1k citations indexed

About

Bing Jiang is a scholar working on Molecular Biology, Biomedical Engineering and Materials Chemistry. According to data from OpenAlex, Bing Jiang has authored 72 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 22 papers in Biomedical Engineering and 21 papers in Materials Chemistry. Recurrent topics in Bing Jiang's work include Advanced Nanomaterials in Catalysis (19 papers), Nanoplatforms for cancer theranostics (17 papers) and Advanced biosensing and bioanalysis techniques (12 papers). Bing Jiang is often cited by papers focused on Advanced Nanomaterials in Catalysis (19 papers), Nanoplatforms for cancer theranostics (17 papers) and Advanced biosensing and bioanalysis techniques (12 papers). Bing Jiang collaborates with scholars based in China, United States and Singapore. Bing Jiang's co-authors include Xiyun Yan, Kelong Fan, Lizeng Gao, Ruofei Zhang, Yili Yang, Jiuyang He, Guohui Nie, Wei Jiang, Yong Long and Weiguo Hu and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Bing Jiang

61 papers receiving 2.1k citations

Hit Papers

High-Performance Self-Cascade Pyrite Nanozymes for Apopto... 2021 2026 2022 2024 2021 2024 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bing Jiang China 23 910 898 780 270 172 72 2.1k
Yi Guo China 22 538 0.6× 780 0.9× 746 1.0× 233 0.9× 203 1.2× 58 1.8k
Tian Huang China 20 817 0.9× 439 0.5× 452 0.6× 166 0.6× 117 0.7× 47 1.6k
Rongrong Jin China 27 943 1.0× 516 0.6× 697 0.9× 546 2.0× 326 1.9× 85 2.3k
Chenyao Wu China 21 981 1.1× 831 0.9× 367 0.5× 377 1.4× 138 0.8× 52 1.8k
Chanjuan Liu China 22 563 0.6× 286 0.3× 412 0.5× 191 0.7× 128 0.7× 64 1.7k
Cheol‐Hee Ahn South Korea 29 805 0.9× 490 0.5× 762 1.0× 931 3.4× 175 1.0× 91 2.7k
Uday Kumar Sukumar India 25 828 0.9× 567 0.6× 869 1.1× 623 2.3× 82 0.5× 60 2.1k
Xingwei Ding China 21 944 1.0× 511 0.6× 464 0.6× 866 3.2× 100 0.6× 44 1.7k
Xiuguo Han China 24 1.1k 1.2× 780 0.9× 902 1.2× 435 1.6× 86 0.5× 34 2.6k
Xufeng Zhu China 25 1.1k 1.2× 776 0.9× 536 0.7× 377 1.4× 50 0.3× 53 1.9k

Countries citing papers authored by Bing Jiang

Since Specialization
Citations

This map shows the geographic impact of Bing Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Jiang more than expected).

Fields of papers citing papers by Bing Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Jiang. The network helps show where Bing Jiang may publish in the future.

Co-authorship network of co-authors of Bing Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Jiang. A scholar is included among the top collaborators of Bing Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Jiang. Bing Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Shenghui, et al.. (2025). Ferritin-Conjugated PROTAC Strategy for ERCC1/XPF Degradation and Platinum Sensitization in Resistant Tumors. Journal of Medicinal Chemistry. 68(18). 19002–19021. 2 indexed citations
2.
Wang, Shuyu, Lulu Wang, Xiyun Yan, & Bing Jiang. (2025). Cascade Catalytic Nanozymes: Design, Classification, and Biomedical Applications. ACS Applied Materials & Interfaces. 17(32). 45354–45381. 6 indexed citations
3.
Bai, Xue, Tingting Wu, Lulu Wang, et al.. (2025). Nanozyme eye drops for retinal barrier penetration and vasculopathy repair. Science Advances. 11(38). eadu5571–eadu5571. 2 indexed citations
4.
Wang, Shaoshuai, Xinru Zhang, Shijun Xu, et al.. (2025). Distribution of Intranasally Administered rIL‐10 Along the Olfactory Nerve and Perivascular Space After Intracerebral Hemorrhage. CNS Neuroscience & Therapeutics. 31(4). e70372–e70372.
5.
Wang, Shuyu, Shenghui Wang, Mengyuan Cao, et al.. (2025). Thermally Gated Dual‐Cascade Nanozyme for Enhanced Mild‐Temperature Photothermal Therapy. Advanced Science. 13(18). e17528–e17528.
6.
Hou, Hui, Jingyi Zhou, Changfa Zhang, et al.. (2025). Discovery of 3-(Fluoro-imidazolyl)pyridazine Derivatives as Potent STING Agonists with Antitumor Activity. Journal of Medicinal Chemistry. 68(10). 9864–9885.
7.
Bai, Xue, Yu Lu, Shuyu Wang, et al.. (2024). The emerging role of nanozymes in ocular antioxidant therapy. Nano Today. 58. 102448–102448. 13 indexed citations
8.
Jiang, Bing, Xuehui Chen, Shenghui Wang, et al.. (2024). Structure-Guided Design of Ferritin–Platinum Prodrugs for Targeted Therapy of Esophageal Squamous Cell Carcinoma. ACS Nano. 18(17). 11217–11233. 10 indexed citations
9.
Geng, Xin, et al.. (2024). Broad-spectrum degradation of fluoroquinolone antibiotics by Hemin-His-Fe nanozymes with peroxidase-like activity. Journal of Materials Chemistry B. 12(35). 8647–8654. 3 indexed citations
10.
Gao, Xuejiao J., Lirong Zhang, Ye Yuan, et al.. (2024). A bioinspired sulfur–Fe–heme nanozyme with selective peroxidase-like activity for enhanced tumor chemotherapy. Nature Communications. 15(1). 10605–10605. 47 indexed citations
11.
Cheng, Ming, et al.. (2024). Optimal Output Power Tracking Method for MCR-WPT Based on DC/DC Converter. 1295–1299. 2 indexed citations
12.
Jiang, Bing, et al.. (2023). Networked Radar Mission Planning Algorithm Based on Pulse Interleaving and Cross-Scheduling Interval. Journal of Physics Conference Series. 2670(1). 12027–12027.
13.
Meng, Xiangqin, Dandan Li, Lei Chen, et al.. (2021). High-Performance Self-Cascade Pyrite Nanozymes for Apoptosis–Ferroptosis Synergistic Tumor Therapy. ACS Nano. 15(3). 5735–5751. 390 indexed citations breakdown →
14.
Zhang, Yanan, Yingni Li, Xuehui Chen, et al.. (2021). Nanocage‐Based Capture‐Detection System for the Clinical Diagnosis of Autoimmune Disease. Small. 17(25). e2101655–e2101655. 12 indexed citations
15.
Fan, Kelong, Bing Jiang, Zhe Guan, et al.. (2018). Fenobody: A Ferritin-Displayed Nanobody with High Apparent Affinity and Half-Life Extension. Analytical Chemistry. 90(9). 5671–5677. 85 indexed citations
16.
Jiang, Bing, et al.. (2017). Macrolide Synthesis through Intramolecular Oxidative Cross‐Coupling of Alkenes. Angewandte Chemie International Edition. 57(2). 555–559. 89 indexed citations
17.
Jiang, Bing, et al.. (2017). Macrolide Synthesis through Intramolecular Oxidative Cross‐Coupling of Alkenes. Angewandte Chemie. 130(2). 564–568. 14 indexed citations
18.
Rong, Ziye, et al.. (2008). [Characterization and analysis of the aggregation of a single-chain chimeric anti-ErbB2 antibody].. PubMed. 24(11). 1918–23. 2 indexed citations
19.
Jiang, Bing, et al.. (2007). [Downregulation of HER2 by adenovirus-mediated RNA interference and its inhibitory effect on growth of SKBR3 breast cancer cell].. PubMed. 23(8). 691–5. 3 indexed citations
20.
Qin, Zhihong, Chun Jiang, Hao Sun, et al.. (2006). GC/MS Analysis of Fractional Extraction of Fusain from Tongting Bituminous Coal in CS2. Journal of China University of Mining and Technology. 16(1). 8–12. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026